In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Deals in Depth: April 2008

Executive Summary

April 2008 dealmaking highlights include: Astellas Pharma penned a $760mm alliance with CoMentis for a novel Alzheimer's disease target; Novartis and Takeda each made billion-dollar acquisitions: Novartis continues to diversify its offerings through the Alcon buy, and Takeda is extending its overseas presence and adding to its cancer pipeline in the Millennium deal. Public investors were absent from biopharma financing, while 25% of medical device investments came from follow-ons.



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts